Objective: The present study was to evaluate clinical parameters around implant surface modified with alendronate. Materials and Methods: 20 patients were randomly divided into two groups (Group I-test and Group II- control). In the test group the osteotomy site was irrigated with bisphosphonate solution and the implant was dipped in the solution and placed in the osteotomy site. In the control group implant the implant was placed as such in the osteotomy site. Soft tissue and hard tissue parameter were recorded at 1st week, 3 months and 6months. Statistical analysis was done. Results: Crestal bone level was evaluated showed no statistically result when observed on mesial and distal aspect at 6 months. Conclusion: Although implant site treated with amino bisphosphonate (local application) showed reduction in the crestal bone loss but it is not statistically significant when compared with control group.
No takes yet. Share an insight, caveat, or question.
Keerthana et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: